Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis

• Pierre Clavelou,
• Giovanni Castelnovo,
• Valérie Pourcher,
• Jerome De Sèze,
• Patrick Vermersch,
• Ali-Frederic Ben-Amor,
• Carine Savarin,
• Gilles Defer

Affiliations

Pierre Clavelou

Department of Neurology, Clermont-Ferrand University Hospital

Giovanni Castelnovo

Department of Neurology, Nîmes University Hospital, Hopital Caremeau

Valérie Pourcher

Department of Infectious and Tropical Diseases, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, INSERM 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique Paris

Jerome De Sèze

Department of Neurology, Strasbourg University Hospital

Patrick Vermersch

Univ. Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise

Ali-Frederic Ben-Amor

Global Medical Affairs Neurology and Immunology, Ares Trading SA (An affiliate of Merck KGaA, Darmstadt, Germany)

Carine Savarin

Neurology Department, Medical Affairs (An affiliate of Merck KGaA, Darmstadt, Germany)

Gilles Defer

Department of Neurology, Caen University Hospital